Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Better Buy: AbbVie vs. Johnson & Johnson

TheMotleyFool

0 0

Better Buy: AbbVie vs. Johnson & JohnsonPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

One company produces the top-selling pharmaceuticals in the world. The other is a household name that offers various consumer health products as well as pharmaceutical products. Both are dealing with some hurdles and challenges.

We're talking about AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ). Are either of these stocks worth buying right now? If so, which is the better buy? Let's take a closer look at each of these healthcare companies.

Image source: Getty Images.

Source Fool.com

Like: 0

JNJ

Teilen